Andrew Dudum - 16 Oct 2025 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum
Issuer symbol
HIMS
Transactions as of
16 Oct 2025
Transactions value $
-$10,725,435
Form type
4
Date filed
20 Oct 2025, 16:42
Previous filing
19 Sep 2025
Next filing
12 Nov 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dudum Andrew Chief Executive Officer, Director, 10%+ Owner 2269 CHESTNUT STREET, #523, SAN FRANCISCO /s/ Kimberly Mather, Attorney-in-Fact for Andrew Dudum 2025-10-20 0001837796

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Sale -$175K -2.79K -2.93% $62.65 92.5K 16 Oct 2025 Direct F1, F2
transaction HIMS Class A Common Stock Sale -$2.45M -39.1K -41.14% $62.70 55.9K 16 Oct 2025 Held by Trustee of Dudum Family Community Property Trust F1, F3
transaction HIMS Class A Common Stock Sale -$535K -8.42K -15.06% $63.46 47.5K 16 Oct 2025 Held by Trustee of Dudum Family Community Property Trust F1, F4
transaction HIMS Class A Common Stock Options Exercise $41.3K +17K +18.37% $2.43 110K 16 Oct 2025 Direct F1
transaction HIMS Class A Common Stock Sale -$1.07M -17K -15.52% $62.69 92.5K 16 Oct 2025 Direct F1, F5
transaction HIMS Class A Common Stock Options Exercise $263K +108K +117.09% $2.43 201K 16 Oct 2025 Direct F1
transaction HIMS Class A Common Stock Sale -$2.48M -39.5K -19.68% $62.71 161K 16 Oct 2025 Direct F1, F6
transaction HIMS Class A Common Stock Sale -$665K -10.5K -6.49% $63.49 151K 16 Oct 2025 Direct F1, F7
transaction HIMS Class A Common Stock Sale -$2.47M -39.3K -26.07% $62.70 112K 16 Oct 2025 Direct F1, F8
transaction HIMS Class A Common Stock Sale -$148K -2.34K -2.09% $63.39 109K 16 Oct 2025 Direct F1, F9
transaction HIMS Class A Common Stock Sale -$1.04M -16.7K -15.26% $62.70 92.5K 16 Oct 2025 Direct F1, F5
holding HIMS Class A Common Stock 1.19M 16 Oct 2025 Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022
holding HIMS Class A Common Stock 1.02M 16 Oct 2025 Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015
holding HIMS Class A Common Stock 1.29M 16 Oct 2025 Held by Trustee of AD 2021 GRAT dated 11-1-2021
holding HIMS Class A Common Stock 187K 16 Oct 2025 Held by Trustee of AD 2025 GRAT dated 5-27-2025
holding HIMS Class A Common Stock 508K 16 Oct 2025 Held by Trustee of AD 2022 GRAT
holding HIMS Class A Common Stock 322K 16 Oct 2025 Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021
holding HIMS Class A Common Stock 1.58M 16 Oct 2025 Held by Trustee of AD 2023 GRAT dated 9-5-2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -17K -49.99% $0.00 17K 16 Oct 2025 Class A Common Stock 17K $2.43 Direct F1, F10
transaction HIMS Stock Option (right to buy) Options Exercise $0 -108K -20.07% $0.00 431K 16 Oct 2025 Class A Common Stock 108K $2.43 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
F2 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.50 - $62.87. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.215 - $63.13. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.31 - $63.59. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F5 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.25 - $62.94. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.22 - $63.18. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F7 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.25 - $63.63. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F8 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $62.22 - $63.20. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F9 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $63.26 - $63.47. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F10 Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
F11 The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.